As the obesity epidemic grows, interventions to mitigate related health complications become increasingly important. In recent years, using medicines off-label for weight loss has become an appealing option for many people. Yet just how wide-spread people's interests are, and what the nature of interest in such options is, is relatively unknown.
Changing lifestyle and diet is recognised for achieving better outcomes for a range of non-communicable diseases, including diabetes. The global burden of diabetes is significant [1], giving rise to the development of pharmaceutical interventions to tackle this epidemic [2]. Semaglutide is an insulin production-targeting drug intended to treat people with diabetes by inducing weight loss [3]. However, the use of this prescribed medication is increasingly being considered in non-medical contexts and especially promoted on social media. Indeed, social media influencers who are endorsing the use of this medicine are suggested to have contributed towards recent worldwide shortages in semaglutide [4].
What inspired this study?
There are a host of medical and non-medical-related factors driving the supply and demand of medicines for weight loss. The interest in off-label use of semaglutide will likely vary between countries and given the far-reaching access to the internet, people’s perspectives on semaglutide can be captured from nations across the globe. The internet is therefore a useful resource in understanding the international viewpoint on semaglutide and Dr Raubenheimer (the lead author for this research) and his co-authors aimed to explore online behaviours to help explain the drivers (often non-clinical) behind the increasing interest in this product.
Why is it important?
A healthy lifestyle can contribute towards prolonging life, preventing disease and reducing economic burdens on healthcare systems. However, maintaining a healthy lifestyle can be challenging—quick fixes become more alluring. This study helps to understand why the use off-label medicine for weight loss (like semaglutide) is of interest across a range of populations, where people’s motives may be influenced by a host of environmental, social and situational factors. Understanding patterns of interest in semaglutide usage may help explain recent shortages in supplies of the drug and conceptualise interventions to prevent this happening again.
Did this study show anything unexpected?
Dr Raubenheimer and colleagues conducted an infodemiology study (a type of epidemiological study using data from internet searches [5]) of Google Trends related to semaglutide between Janurary 2021 and August 2023. The findings highlight some countries where there was increased interest in semaglutide, although media coverage only partly explained the interest. There were specific media and social media events of note that the authors indicated to spike online interest in semaglutide across numerous countries, including an episode of the Dr Oz Show and tweets from Elon Musk. Dr Raubenheimer’s team thematically analysed the Google Trends data, highlighting that weight loss (but not diabetes) was a major theme across most countries related to searches for semaglutide. Interest in many countries was also dominated by searches on how to obtain semaglutide.
What is the wider significance of the study findings?
The study illuminates the potential power of the internet in exploring what drives people's interests to search for information about medicinal weight loss interventions. The trends identified in different countries may elucidate specific drivers underlying the increased interest in semaglutide, which may be attributed to off-label use for non-clinical purposes. The subsequent shortage in semaglutide, potentially as a consequence of the rapidly growing interest online, may prevent these medicines reaching those who need it most. Furthermore, supply and demand challenges may increase the production of counterfeit and unregulated medicines flooding the markets, further exacerbating the problem.
References
- World Health Organization (WHO). The top 10 causes of death. Fact Sheets. 2020. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed 19 May 2023.
- Khan N. How to ‘drug’ our way out of the obesity crisis (or not): the roll-out of semaglutide. Br J Gen Pract. 2024;74:218–218.
- Walmsley R, Sumithran P. Current and emerging medications for the management of obesity in adults. Med J Aust. 2023;218:276–83.
- Therapeutic Goods Administration (TGA). About the Ozempic (semaglutide) shortage 2022 and 2023. Therapeutic Goods Administration (TGA). 2022. https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-ozempic-semaglutide-shortage-2022-and-2023. Accessed 12 Feb 2024.
- Eysenbach G. Infodemiology and Infoveillance: Tracking online health information and cyberbehavior for public health. Am J Prev Med. 2011;40:S154–8.
Follow the Topic
-
BMC Global and Public Health
An open access, transparent peer review journal publishing outstanding and influential research and opinion of broad interest to all professional communities involved in global and public health research, policy-making, implementation and delivery worldwide.
Related Collections
With Collections, you can get published faster and increase your visibility.
Ensuring continuity of care in LMICs
BMC Global and Public Health is calling for submissions to our Collection on ensuring continuity of care in low- and middle-income countries (LMICs). In the realm of global health, one of the persistent challenges facing LMICs is ensuring the delivery of integrated, coordinated, and continuous care across healthcare services. The concept of seamless care is paramount, aiming to guarantee that individuals receive integrated and coordinated healthcare across different levels of the healthcare system and over time. This Collection seeks to shed light on innovative strategies, research findings, and practical solutions in LMICs.
We invite contributions that explore various dimensions of integrated, coordinated and continuous care of care in LMICs, including but not limited to:
Health System Strengthening: Investigations into approaches for strengthening health systems in LMICs to support seamless access to healthcare services. This may include efforts to improve infrastructure, enhance workforce capacity, and optimize service delivery models.
Integrated Care Models: Exploration of integrated care approaches that facilitate collaboration among diverse healthcare providers, services, and institutions. These models aim to improve care coordination, referrals, and counter-referrals, reduce fragmentation, and enhance the patient experience.
Digital Health Solutions: Assessments of the role of digital health technologies in enhancing continuity of care in LMICs. This may include the use of electronic health records, telemedicine, mobile health applications, AI, and other innovative digital tools to overcome barriers to access and improve healthcare delivery.
Community-Based Care: Studies on community-based healthcare initiatives that empower communities to take ownership of their health and well-being. These initiatives often play a crucial role in ensuring ongoing access to essential healthcare services, particularly in remote or underserved areas.
Policy and Governance: Examination of policy and governance frameworks aimed at promoting continuity of care in LMICs. This may include analyses of healthcare financing mechanisms, regulatory frame.
This Collection supports and amplifies research related to SDG 3: Good Health and Well-being by advancing our understanding of continuity of care and contributing to efforts to ensure equitable access to quality healthcare services for all populations, regardless of geographical location or socioeconomic status.
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Apr 23, 2026
Infectious disease modeling: Impact on public health practices
BMC Global and Public Health is calling for submissions to our Collection on innovative approaches that advance our understanding of health issues impacting communities worldwide. This Collection will serve as a forum for sharing research that improves our ability to respond to critical challenges in disease control and prevention, fostering resilience in health systems and enhancing public health preparedness.
The aim of this Collection is to explore the dynamic field of infectious disease research and the critical insights it provides for effective public health interventions. We seek original studies, reviews, and case reports that shed light on how predictive methods and analyses can inform decision-making and improve health outcomes. Potential topics include, but are not limited to:
• Use of mathematical and statistical approaches to simulate disease transmission
• Novel methods for forecasting and early warning systems for disease outbreaks
• Evaluating the impact of vaccination and other preventive measures on disease dynamics
• Analysis of vector-borne disease spread and control strategies under changing environmental conditions
• Integration of socioeconomic and demographic factors in risk assessment models
• Machine learning and AI applications in infectious disease prediction
• Incorporating One Health perspectives to understand zoonotic transmission risks.
We encourage work from local, regional, national, and global partnerships and collaboration among multidisciplinary scientists using multiple methodologies. We ask that authors be careful to use non-stigmatizing/preferred language in their manuscripts as outlined in relevant language guidelines for their respective fields.
Contributions to this Collection will provide valuable insights to guide policy-making and practical solutions in public health. We invite researchers, practitioners, and policymakers to share evidence that advances our understanding of how to better predict and mitigate the impact of infectious diseases on populations, especially those disproportionately affected by health inequities.
This Collection supports and amplifies research related to SDG 3: Good Health and Well-being.
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Apr 23, 2026
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in